Edgar Snyder & Associates®
A Law Firm Representing Injured People
1-866-943-3427
Call Us Toll Free 24/7
Published on Aug 22, 2012 by Edgar Snyder

Blood Thinner Pradaxa Part of Multidistrict Lawsuit

pradaxa lawsuit

Millions of people across the country have been prescribed the blood thinner Pradaxa (Dabigatran) to treat an irregular heartbeat. Recently, thousands of adverse reports related to the drug have led to a multidistrict lawsuit against its manufacturer.

In 2011, 3,781 adverse effects and 542 deaths associated with Pradaxa were reported to the FDA. Dangerous reactions included gastrointestinal bleeding, hemorrhaging, and heart attack. In fact, Pradaxa had the highest number of deaths among all drugs reported last year.

Hundreds of patients have joined a multidistrict lawsuit to go up against the dangerous drug and its manufacturer, Boehringer Ingleheim. In about a year, a panel of judges will hear from patients chosen to represent the hundreds of claims currently filed by people who suffered adverse reactions to Pradaxa.

The FDA is currently conducting a safety review of Pradaxa to determine whether the reports of bleeding are occurring more commonly than would be expected. The FDA says that patients prescribed Pradaxa should not stop taking it without talking to their healthcare provider first.

Free Case Review
First Name
Last Name
ZIP
Phone
Email
Briefly describe your injuries
"Blood thinner Pradaxa target of mass-claims suit." USA Today. August 20, 2012.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
ZIP
Phone
Email
Briefly describe your injuries

Recent News

Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers
Sep 16, 2016
New CDC Tool Will Help Keep Traveling Workers Safe
Tweet